Rigel Pharmaceuticals Inc balance sheet

At the end of fiscal 2025, Rigel Pharmaceuticals Inc had total assets of $514m, total liabilities of $122m and shareholders' equity of $391m. It held $40.6m in cash against $52.5m of debt: net debt of $11.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Rigel Pharmaceuticals Inc: balance sheet, annual
Fiscal year	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	18	38	76	23	30	19	24	33	57	41	61
Receivables	0	0	4	10	16	15	40	31	42	52	56
Inventory	—	—	1	1	2	7	9	6	6	12	14
Total current assets	76	117	137	119	89	154	116	99	135	240	186
Total assets	78	119	139	148	110	167	134	117	164	514	521
Accounts payable	6	3	6	4	4	4	23	7	3	7	4
Deferred revenue (current)	—	—	1	25	3	3	1	1	1	1	—
Total current liabilities	23	18	28	58	41	64	65	53	63	99	96
Long-term debt	—	—	—	10	20	20	40	60	60	53	—
Total debt	0	0	0	10	20	20	40	60	60	53	40
Total liabilities	—	—	—	—	—	137	148	146	161	122	96
Shareholders' equity	55	101	110	54	34	30	−14	−29	3	391	425
Net debt (negative = net cash)	−18	−38	−76	−13	−10	1	16	27	3	12	−21
Shares outstanding	—	—	—	—	—	—	—	17m	18m	18m	—

US$ millions unless shown otherwise. Fiscal quarters.

Rigel Pharmaceuticals Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	31	42	42	40	46	52	50	56
Inventory	5	6	5	10	13	12	12	14
Total current assets	106	135	147	175	215	240	234	186
Total assets	139	164	176	207	243	514	505	521
Accounts payable	4	3	4	7	4	7	4	4
Deferred revenue (current)	1	1	1	1	1	1	—	—
Total current liabilities	54	63	67	87	94	99	89	96
Long-term debt	60	60	60	60	60	53	45	—
Total debt	60	60	60	60	60	53	45	—
Total liabilities	154	161	157	125	125	122	105	96
Shareholders' equity	−15	3	19	82	118	391	400	425
Shares outstanding	—	18m	—	—	—	18m	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: HROW vs RIGL EOLS vs RIGL ACB vs RIGL

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Rigel Pharmaceuticals Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Rigel Pharmaceuticals Inc.